|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Impairment of right-of-use assets | |||||
| Amortization of debt issuance costs | |||||
| Amortization of gains on derivatives | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value of contingent consideration | |||||
| Gains on equity securities | |||||
| Other non-cash items | |||||
| Deferred taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current and non-current assets | |||||
| Operating lease right-of-use assets | |||||
| Accrued compensation | |||||
| Accounts payable, accrued liabilities, and other current liabilities | |||||
| Operating lease liabilities, non-current | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Business combinations, net of cash acquired | |||||
| Purchases of software and capitalized software development costs | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of equity securities | |||||
| Acquisitions of HSA portfolios | |||||
| Settlement of derivatives, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal payments on long-term debt | |||||
| Repurchases of common stock | |||||
| Proceeds from long-term debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from follow-on equity offering, net of payments for offering costs | |||||
| Settlement of client-held funds obligation, net | |||||
| Proceeds from exercise of common stock options | |||||
| Payment of contingent consideration | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Beginning cash and cash equivalents | |||||
| Ending cash and cash equivalents | |||||
| Supplemental cash flow data: | |||||
| Interest expense paid in cash | |||||
| Income tax payments, net | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Purchases of software and capitalized software development costs included in accounts payable, accrued liabilities, or accrued compensation | |||||
| Computer Software, Intangible Asset | |||||
| Acquired HSA portfolios | |||||
| Total purchases of software and capitalized software development costs included in accounts payable, accrued liabilities, or accrued compensation | |||||
| Purchases of property and equipment included in accounts payable or accrued liabilities | |||||
| Increase in goodwill due to measurement period adjustments, net | |||||
| Repurchases of common stock included in accrued liabilities | |||||
| Non-cash purchase consideration related to acquisitions of HSA portfolios | |||||
| Settlement of derivatives included in other current assets | |||||
| Exercise of common stock options receivable | |||||
Loading...